Dr. Sara Buhrlage of the Dana-Farber Cancer Institute presents
October 7 @ 4:00 pm - 5:00 pm
Sara Buhrlage, PhD
Associate Professor
Department of Biological Chemistry and Molecular Pharmacology
Harvard University Medical School and the
Dana-Farber Cancer Institute
Seminar Title: “TBD”
Please join us and show support for our seminar speakers!
(For those unable to attend, a zoom link is available upon request to Mimi Baltz.)
Hosts: Mike Emanuele and Nick Brown
From the Buhrlage Lab website: “Our mission is to revolutionize our ability to interrogate deubiquitinase (DUB) biology, validate DUBs as therapeutic targets, and develop small molecule-based ligands suitable for clinical development. To accomplish this, we have established an integrated DUB-centric platform comprised of DUB-targeted libraries with novel scaffolds and chemotypes and a suite of established and novel biochemical and chemoproteomic assays to profile compound activity and selectivity, as well as expertise in DUB medicinal chemistry, structural biology, computational chemistry, and functional annotation.” ~ https://buhrlagelab.dana-farber.org/